Quantcast
Last updated on April 23, 2014 at 21:24 EDT
Drug Treatment And Weight Loss Can Restore Vision Loss Study

Drug Treatment And Weight Loss Can Restore Vision Loss: Study

NIH/National Eye Institute An inexpensive glaucoma drug, when added to a weight loss plan, can improve vision for women with a disorder called idiopathic intracranial hypertension (IIH), according to a study funded by the National Institutes of...

Latest Clinical research Stories

2014-04-23 20:23:18

DUBLIN, Ireland, April 23, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/7wz5xs/general_review_of) has announced the addition of the "General Review of Clinical Trial Environment in Japan 2014" [http://www.researchandmarkets.com/research/7wz5xs/general_review_of ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) In Japan, companies begin researching and developing...

2014-04-23 16:30:40

DUBLIN, April 23, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/b57g7v/global_vitamin_d) has announced the addition of the "Global Vitamin D Testing Market 2014-2018" [http://www.researchandmarkets.com/research/b57g7v/global_vitamin_d ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The analysts forecast the Global Vitamin D Testing Market to grow at a CAGR of 32.36 percent over...

2014-04-23 12:30:25

Program Will Drive Research Collaboration, Enhance Site Sustainability ELLICOTT CITY, Md., April 23, 2014 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS) is proud to announce the launch of its newest initiative, the Site Advocacy Group (SAG). SCRS is honored to have TransCelerate BioPharma Inc. ("TransCelerate") as its SAG partner. The SAG is a landmark industry initiative that enables clinical investigators and site professionals to interact directly with senior...

2014-04-23 12:29:32

PRINCETON, N.J., April 23, 2014 /PRNewswire/ -- The WIRB-Copernicus Group ("WCG"), the world's largest provider of regulatory and ethical review services for clinical research, announced today that David Forster, J.D., M.A., C.I.P., the Company's Chief Compliance Officer, will be a featured speaker at the 2014 Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP) Annual Conference being held April 23-25 in Salt Lake City, Utah....

2014-04-23 08:40:38

BOSTON, April 23, 2014 /PRNewswire/ -- Clinical trial sponsors working to standardize the capture and submission of complex imaging data through new QIBA imaging charters now have an easy and effective way to ensure the protocols are being met. AG Mednet's Submission, Quality and Compliance (SQC) software for QIBA is the first technology to automate the process of verifying QIBA protocol compliance, saving sponsors time and money and making it easier for investigator sites to submit...

2014-04-23 08:31:14

CHARLOTTESVILLE, Va., April 23, 2014 /PRNewswire/ -- HemoShear, LLC, the human disease biology company, today announced research collaboration with Medivir AB of Stockholm, Sweden, an emerging research-based pharmaceutical company focused on infectious diseases. The collaboration will explore the application of HemoShear's platform in an undisclosed area of strategic interest. In this initial phase of the collaboration, HemoShear will characterize biological mechanisms and the effects...

2014-04-23 08:30:49

TAIPEI, April 23, 2014 /PRNewswire/ -- TWi Pharmaceuticals, Inc. today announced that it has entered into a settlement agreement with Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc. to settle all outstanding patent litigation related to TWi's lidocaine topical patch 5% product. An Abbreviated New Drug Application (ANDA) for TWi's product is currently under review at the U.S. Food and Drug Administration (FDA). If approved, TWi's product would be a...

2014-04-23 00:21:13

DUBLIN, April 23, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/3t5r4b/companion) has announced the addition of the "Companion Diagnostics: Market Size, Segmentation, Growth, Competition and Trends" [http://www.researchandmarkets.com/research/3t5r4b/companion ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Companion diagnostics (CDx) is an emerging (+$200M) segment of the -$50B in...

2014-04-22 23:14:55

On April 18, the FDA announced the nationwide recall of seven lots of Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL) by Hospira due to a glass defect. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) April 22, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for drugs including...

2014-04-22 12:31:41

LONDON, April 22, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Bone Cancer Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/drug_discovery/bone_cancer_global_clinical_trials_review_h1_2014.html Bone Cancer Global Clinical Trials Review, H1, 2014 SummaryGlobalData's clinical trial report, "Bone Cancer Global Clinical Trials Review, H1, 2014" provides data on the Bone Cancer clinical trial scenario. This report...